|
Intraventricular rt-PA in Patients with Intraventricular Hemorrhage Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Intraventricular rt-PA in Patients with Intraventricular Hemorrhage conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Intraventricular rt-PA in Patients with Intraventricular Hemorrhage Clinical research trials and Intraventricular rt-PA in Patients with Intraventricular Hemorrhage medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Intraventricular rt-PA in Patients with Intraventricular Hemorrhage. Intraventricular rt-PA in Patients with Intraventricular Hemorrhage Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Intraventricular rt-PA in Patients with Intraventricular Hemorrhage clinical trial. Participants frequently obtain the most expert healthcare available for their Intraventricular rt-PA in Patients with Intraventricular Hemorrhage condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "I" Clinical Trials Conditions > Intraventricular rt-PA in Patients with Intraventricular Hemorrhage  Intraventricular rt-PA in Patients with Intraventricular Hemorrhage
Intraventricular rt-PA in Patients with Intraventricular Hemorrhage
For Condition: Cerebral Hemorrhage
Status: Recruiting
Sponsor(s): FDA Office of Orphan Products Development ,
Synopsis: This is a study to evaluate how recombinant tissue plasminogen activator (rt-PA) is utilized in patients with intraventricular hemorrhage (IVH). rt-PA is a drug that has been shown to dissolve blood, and may allow intraventricular catheters to be more effective for a longer period of time.
Details: IVH occurs in about 40 percent of intracerebral hemorrhage cases and 15 percent of aneurysmal subarachnoid hemorrhage cases. Evidence supports a strong contribution of IVH to morbidity and mortality after cerebral hemorrhage. External ventricular drainage (EVD) is required clinical management; however, EVD via intraventricular catheter alone fails to prevent much of the morbidity and mortality of IVH. This study seeks to demonstrate the safety and efficacy of intraventricular thrombolysis, using rt-PA, as a method of removing this blood and altering morbidity and mortality. Patients will receive intraventricular injections of rt-PA or placebo every 12 hours. They will be followed prospectively with daily head CT scans during the acute-treatment phase and again between Days 28 and 32.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Pharmacokinetics/Dynamics Study
Minimum Age/Maximum Age: 18 Years/75 Years
Genders: Both
Protocol Entry Criteria: Inclusion criteria: - Intraventricular hemorrhage (IVH) confirmed by CT scan - More than 12 hours post bleed - Hematoma size stable by CT scan - Post-IVH catheter CT scan - Able to begin study within 24 hours of bleed Exclusion criteria: - Infratentorial bleed - Supratentorial bleed greater than 30 cc - Unclipped aneurysm suspected - Arteriovenous malformation suspected - Any severe, complicating illness (e.g., AIDS or DNR) - Cardiovascular parameters that could confound study (e.g., myocardial infarction, pulmonary emboli, systemic fibrinolysis) - Active internal bleeding - Requirement for heparin doses greater than 10,000 U/day - Concurrent coumadin - Known allergy to rt-PA - Pregnancy
Total Enrollment: 30
Location and Contact Information:
The Johns Hopkins University *Recruiting*
Baltimore, Maryland, 21287
United States
Recruiting Daniel Hanley 410-614-6996
Additional Information:
Study ID Numbers: FD-R-2018-01; FD-R-002018-01
Study Start Date: September 2001
Record last reviewed: December 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00029315
Other Cerebral Hemorrhage Studies:
1. Intraventricular rt-PA in Patients with Intraventricular Hemorrhage
Related Studies:
Other Cerebral Hemorrhage Clinical Trials
Other Maryland Clinical Trials
Other Baltimore Clinical Trials
Intraventricular rt-PA in Patients with Intraventricular Hemorrhage
|
|
|
|
|
|
|
|
